Anti-OXYR/ OTR/ OXTR monoclonal antibody

Anti-OXYR/ OTR/ OXTR antibody for FACS & in-vivo assay

Target products collectionGo to OTR/OXTR products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T84486-Ab-1/ GM-Tg-hg-T84486-Ab-2Anti-Human OTR/OXTR monoclonal antibodyHuman
GM-Tg-rg-T84486-Ab-1/ GM-Tg-rg-T84486-Ab-2Anti-Rat OTR/OXTR monoclonal antibodyRat
GM-Tg-mg-T84486-Ab-1/ GM-Tg-mg-T84486-Ab-2Anti-Mouse OTR/OXTR monoclonal antibodyMouse
GM-Tg-cynog-T84486-Ab-1/ GM-Tg-cynog-T84486-Ab-2Anti-Cynomolgus/ Rhesus macaque OTR/OXTR monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T84486-Ab-1/ GM-Tg-felg-T84486-Ab-2Anti-Feline OTR/OXTR monoclonal antibodyFeline
GM-Tg-cang-T84486-Ab-1/ GM-Tg-cang-T84486-Ab-2Anti-Canine OTR/OXTR monoclonal antibodyCanine
GM-Tg-bovg-T84486-Ab-1/ GM-Tg-bovg-T84486-Ab-2Anti-Bovine OTR/OXTR monoclonal antibodyBovine
GM-Tg-equg-T84486-Ab-1/ GM-Tg-equg-T84486-Ab-2Anti-Equine OTR/OXTR monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T84486-Ab-1/ GM-Tg-hg-T84486-Ab-2; GM-Tg-rg-T84486-Ab-1/ GM-Tg-rg-T84486-Ab-2;
GM-Tg-mg-T84486-Ab-1/ GM-Tg-mg-T84486-Ab-2; GM-Tg-cynog-T84486-Ab-1/ GM-Tg-cynog-T84486-Ab-2;
GM-Tg-felg-T84486-Ab-1/ GM-Tg-felg-T84486-Ab-2; GM-Tg-cang-T84486-Ab-1/ GM-Tg-cang-T84486-Ab-2;
GM-Tg-bovg-T84486-Ab-1/ GM-Tg-bovg-T84486-Ab-2; GM-Tg-equg-T84486-Ab-1/ GM-Tg-equg-T84486-Ab-2
Products NameAnti-OTR/OXTR monoclonal antibody
Formatmab
Target NameOTR
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-OTR benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species OXYR/ OTR/ OXTR VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP003633human OXTR Lentivirus plasmid
    ORF Viral VectorvGMLP003633human OXTR Lentivirus particle
    ORF Viral VectorpGMLPm004375mouse Oxtr Lentivirus plasmid
    ORF Viral VectorvGMLPm004375mouse Oxtr Lentivirus particle


    Target information

    Target IDGM-T84486
    Target NameOTR
    Gene ID5021,18430,25342,702048,484670,101081711,281371,106781784
    Gene Symbol and SynonymsOT-R,OTR,OTR1,OXTR
    Uniprot AccessionP30559,P70536,P56494,P56449
    Uniprot Entry NameOXYR_HUMAN,OXYR_MACMU,OXYR_RAT,OXYR_BOVIN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000180914
    Target ClassificationGPCR

    The target: OTR, gene name: OXTR, also named as OT-R. The protein encoded by this gene belongs to the G-protein coupled receptor family and acts as a receptor for oxytocin. Its activity is mediated by G proteins which activate a phosphatidylinositol-calcium second messenger system. The oxytocin-oxytocin receptor system plays an important role in the uterus during parturition. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.